• Home
  • About Risky Finance
  • Nick Dunbar
    • The Devil’s Derivatives
    • Inventing Money
    • About Nick Dunbar
  • Follow us
subscribe
Login
Menu
  • Visualisation tools
    • Currencies
    • Corporate bonds
    • UK Local government
    • Asset Management
    • Sovereign
    • Banking
    • Sovereign (old version)
    • Equities
    • Inflation
  • Articles
    • Stocks
    • Pensions
    • Banks
    • Credit
    • Technology
    • Economics
    • Municipal Finance
    • Funds
  • Reviews & research
    • Book Reviews
Homemedicine

Viruses: Agents of Evolutionary Invention

2 November 2021Book Reviewsbiology, Covid-19, evolution, medicineNick Dunbar

Dozens of books have already been published on the pandemic, and many are already out of date. To appreciate Covid, it’s best to step back and read this account of viruses published four years ago.

Continue reading..

How my ancestors helped me through the pandemic

5 January 2021Book ReviewsCovid-19, medicine, pandemicsNick Dunbar

The experience of a doctor who fought pandemics a century and a half ago provides some hope for today

Continue reading..

The stem cell challenge

19 October 2010Articleslongevity risk, medicine, science, stem cellsNick Dunbar

Last weekend, I attended a lecture given by Douglas Melton, the director of Harvard University's Stem Cell Institute. Stem cells are the medical equivalent of the philosophers' stone, especially those in human embryos which spontaneously differentiate themselves into heart, brain, liver and other cells that make up the body. The stem cells we possess as…

Continue reading..

Join our mailing list

  • Recent Articles
  • Recent Charts
  • Understanding Goldman's $...
    The bank may look profitable to shareholders, but ...
  • Battle of the yield curve...
    Bond investors have started to notice France's pol...
  • Agents of change
  • Levelling the Playing Fie...
    How to get in early and work with AI before it tra...
  • EU bank corporate loan exposure by country
  • Interest rate benchmark rigging fines & prosecutions
  • Quarterly R&D expense for companies with AI activity
  • Central bank bond holdings as a percentage of outstanding debt
  • Most Viewed
  • Most Commented
  • Burning down the house

  • Much ado about FX swaps

  • The rise of the leveraged brokers

  • Crunch time for LOBO derivatives

  • Cash positioning for an upwards rate shock

  • How JP Morgan broke the repo market
  • How Covid-19 infected the corporate bond market
  • Deutsche Bank and the Big Short
  • Giants of the S&P500
  • Nature Bites Back In New, Messy World of Derivatives

  • Contact
  • Help
  • Contribute
  • Terms & Conditions

Copyright © 2025, Risky Finance . All rights reserved.